Molecular docking and in silico ADME prediction of Ticagrelor as an antagonist of the P2Y12 receptor

Authors: not saved
Abstract:

The purpose of the present research work is prediction of electronic and physico-chemical properties of the novel medicinal compound Ticagrelor (AZD6140) using density functional theory (DFT) method. Firstly, its molecular structure was optimized at B3LYP/6-311++G(d,p) basis set of theory at room temperature. The global reactivity indices used to study the reactivity and stability of the title molecule. These indices showed it is a more stable molecule and has low reactivity. On the other hand, the molecular electrostatic potential (MEP) graph indicates the hetero-atoms (N, F, S and O) of the molecule can interact with residues of the receptor. The molecular docking analysis data indicates the P2Y12 residues containing Lys 232, Lys 125, Thr 126, Glu 215, Arg 231, Ile 212, Asn 235, Thr 127, Lys 233, Arg 128, Tyr 123 and Lys 237 are the main amino acids which participate in the ligand-receptor complex formation. Evaluation of intramolecular bonds shows that the steric interactions play the main role in the ligand-receptor complex formation.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Ticagrelor: The First Reversibly Binding Oral P2Y12 Receptor Antagonist

Ticagrelor (AZD6140) is the first reversibly binding oral P2Y(12) receptor antagonist that blocks ADP-induced platelet aggregation. Unlike thienopyridines, which irreversibly bind to the P2Y(12) receptor for the lifetime of the platelet, ticagrelor binds reversibly to the receptor and exhibits rapid onset and offset of effect, which closely follow drug exposure levels. Animal models indicate gr...

full text

Physicochemical properties analysis and dopamine D2 receptor (D2R) docking of zotepine as an atypical antipsychotic antagonist

The main purpose of the present investigation is the study of therapeutically effect of Zotepine in schizophrenia disease treatment. In first step, the molecular structure of the said compound is optimized using density functional theory (DFT) technique by B3LYP functional method at 6-311++G(d,p) level of theory. Then the electronic properties of the title molecule are calculated using frontier...

full text

Molecular docking, 3D-QSAR studies, and in silico ADME prediction of p-aminosalicylic acid derivatives as neuraminidase inhibitors.

Neuraminidase (NA) is a major glycoprotein of influenza virus which is essential for viral infection. It offers a potential target for antiviral drug design and discovery. To develop novel potent neuraminidase inhibitors (NAI), Surflex-Dock was employed to dock 40 hydrophobic p-aminosalicylic acid derivatives into the active site of NA. The 3D-quantitative structure-activity relationship studie...

full text

In silico Prediction and Docking of Tertiary Structure of LuxI, an Inducer Synthase of Vibrio fischeri

Background: LuxI is a component of the quorum sensing signaling pathway in Vibrio fischeri responsible for the inducer synthesis that is essential for bioluminescence. Methods: Homology modeling of LuxI was carried out using Phyre2 and refined with the GalaxyWEB server. Five models were generated and evaluated by ERRAT, ANOLEA, QMEAN6, and Procheck. Results: Five refined models were gener...

full text

In silico prediction of ADME and pharmacokinetics

The computational approach is one of the newest and fastest developing techniques in pharmacokinetics, ADME (absorption, distribution, metabolism, excretion) evaluation, drug discovery and toxicity. However, to date, the software packages devoted to ADME prediction, especially of metabolism, have not yet been adequately validated and still require improvements to be effective. Most are ‘open’ s...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 16  issue Issue 2 (Fall 2019 and Winter 2020) 3 and 4

pages  91- 102

publication date 2020-02-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023